24
Apr

Sanofi is again trimming its oncology pipeline, walking away from an armed-antibody cancer treatment licensed from ImmunoGen as it reshapes its approach to the field.

…read more

Source: Sanofi dumps an ImmunoGen cancer drug as it scales back in oncology

    

0 No comments